AIDX logo

AIDX 20/20 Biolabs Inc.

NASDAQ · Medical - Care Facilities · Healthcare

$0.20
-0.03 (-12.76%)

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (C…

Market Cap: $2.62M2020biolabs.com

Price

No data yet.

Social Signal Score

51
5d
—
30d
50
2 mentions
—
60d
50
4 mentions
—
90d
54
5 mentions
—
news: 5

Analyst Ratings

Avg price target$5+2448.4%
Low $5Median $5High $5
Current Consensus

Revenue

$730.6K+664.44%
$62.8K$1.70M$3.33M$4.96M
Mar 2016Jun 2026

Analyst Estimates

FY2026
$-0.52
$-0.52–$-0.52
1 analysts
FY2027
$-0.38
$-0.38–$-0.38
1 analysts
FY2028
$-0.47
$-0.47–$-0.47
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Jonathan Cohen
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
14
Beta
1.54
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-9.63
2020biolabs.com